First, blockade of CXCL1, a critical chemokine to attract neutrophils, via the disruption of the Cxcl1 gene or treatment with a neutralizing anti-CXCL1 antibody, reduced hepatic neutrophil infiltration and liver fibrosis. The gene discussed is CXCL1; the disease is Hepatic fibrosis.